Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Sharonjit K DhillonCocuzza Clementina ElveziaPui Yan Jenny ChungMarianna MartinelliChiara GiubbiRuth C NjokuRamya BhatiaKate CuschieriMarc ArbynPublished in: Journal of medical virology (2022)
OncoPredict HPV® SCR fulfills the three international validation criteria for hrHPV DNA tests in cervical cancer screening. This article is protected by copyright. All rights reserved.